Atlas Trials

Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus

Clinical trial NCT00117702 · TERMINATED

Trial details

NCT number
NCT00117702
Sponsor
Technische Universität Dresden
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Graft vs Host Disease
Start date
2005-10-01
Primary completion
2008-05-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.